PospisilikJAStaffordSGDemuthHUBrownseyRParkhouseWFinegoodDTet al
OCPs should be prescribed as a continuous, non-cyclic regimen
it reflects pharmacokinetics only., Weigh the indication: More conservative avoidance is typically used for elective weight loss, while diabetes management may require individualized planning with obstetric care. Estimated washout timelines (drug clearance, not infant safety) Bottom line breastfeeding and GLP-1 medications While no evidence proves harm, many clinicians currently recommend avoiding GLP-1 medications for weight loss during breastfeeding
Photo by Innerbody Research Around 30-50% of American adults dont get enough sleep.1 The consequences of this insufficiency can be steep, as without a regular 7-8 hours rest per night, a person can find themselves at risk for depression, decreased cognitive function, and an increased risk of cardiovascular and endocrine dysfunction.2 For the many millions of people with sleep deficiency, a peptide called DSIP could be a solution, although some researchers might disagree
Once-weekly dulaglutide versus bedtime insulin glargine, both in combination with prandial insulin lispro, in patients with type 2 diabetes (AWARD-4): a randomised, openlabel, phase 3, non-inferiority study
Clinical trials show that slow dose escalation reduces adverse event severity by 40-50% compared to rapid initiation protocols
